APIM050295: BIRINAPANT
CAS No.: 1260251-31-7.
Purity: 99.5% by HPLC.
QC: HPLC-MS, 1HNMR, Chiral HPLC and Quantitative Elemental Analysis.
Solubility: Soluble in DMSO.APIM050295: BIRINAPANT
CAS No.: 1260251-31-7.
Purity: 99.5% by HPLC.
QC: HPLC-MS, 1HNMR, Chiral HPLC and Quantitative Elemental Analysis.
Solubility: Soluble in DMSO.BP000970-PKA-340: Recombinant Human C-erbB2 Protein
Source: E.coli-derived.
Purity > 95%, by SDS-PAGE.BP001618-C110: Recombinant Human Carbonic Anhydrase 5B (CA5B) Enzyme
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP001837-PRO-211: Recombinant Human Calcium Binding Protein 7 (CABP7)
Source: E. coli-derived.
Purity: > 80.0% as determined by SDS-PAGE.BP001614-CA21: Recombinant Human Calcitonin (CALCA) Protein
Source: HEK 293-derived.
Purity: > 95% by reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP001839-PRO-279: Recombinant Human Calnueron-1 (CALN1) Protein
Source: E. coli-derived.
Purity: > 90.0% as determined by SDS-PAGE.C028P: Camrelizumab Biosimilar, PD-1 Monoclonal Antibody
Recombinant Humanized IgG4-k Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade camrelizumab biosimilar specifically binds to the programmed cell death protein 1 (PD1), antagonizing its interaction with its known ligands PD-L1 and PD-L2.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by camrelizumab.BP001615-C566: Recombinant Human Calnexin (CANX) Protein
Source: HEK 293-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP001615-PRO-725: Recombinant Human Calnexin (CANX) Protein
Source: E. coli-derived.
Purity: > 90% by SDS-PAGE.